Bellini Roberto
SEC insider (Form 3/4/5 filer). CIK 0001802453. Director at Inhibikase Therapeutics, Inc. (IKT). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2025. Located in ATLANTA, GA.
Companies Bellini Roberto has filed insider reports for
- Inhibikase Therapeutics, Inc. (IKT): Director
Bellini Roberto
CIK: 0001802453
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Inhibikase Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 30, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
108.2K shares- - Feb 14, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
73.6K shares- - Feb 14, 2025IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
116.6K shares- - Oct 21, 2024IKT
Inhibikase Therapeutics, Inc.
PurchaseIndirect1.5M shares at avg. $1.37$2.0M - Oct 21, 2024IKT
Inhibikase Therapeutics, Inc.
AwardDirectStock Option (right to buy)
60K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 108,176 | - | - | Direct |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 73,580 | - | - | Direct |
| Feb 14, 2025 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (Right to Buy) | 116,585 | - | - | Direct |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | Purchase | 1,460,000 | $1.37 | $2,000,200 | Indirect |
| Oct 21, 2024 | IKT Inhibikase Therapeutics, Inc. | Award Stock Option (right to buy) | 60,000 | - | - | Direct |
1-5 of 5 transactions